Shagun Singh
Stock Analyst at RBC Capital
(2.68)
# 1,118
Out of 4,641 analysts
177
Total ratings
56.67%
Success rate
-0.25%
Average return
Main Sectors:
Stocks Rated by Shagun Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ISRG Intuitive Surgical | Maintains: Outperform | $525 → $555 | $512.46 | +8.30% | 13 | Oct 18, 2024 | |
| JNJ Johnson & Johnson | Maintains: Outperform | $178 → $181 | $164.26 | +10.19% | 15 | Oct 16, 2024 | |
| MDT Medtronic | Upgrades: Outperform | $98 → $105 | $91.83 | +14.34% | 19 | Oct 10, 2024 | |
| ZYXI Zynex | Maintains: Outperform | $12 → $11 | $8.47 | +29.95% | 5 | Oct 8, 2024 | |
| ZBH Zimmer Biomet Holdings | Maintains: Outperform | $130 → $120 | $105.30 | +13.96% | 11 | Oct 8, 2024 | |
| TFX Teleflex | Maintains: Outperform | $260 → $275 | $238.57 | +15.27% | 18 | Oct 8, 2024 | |
| PEN Penumbra | Maintains: Outperform | $205 → $222 | $207.04 | +7.23% | 10 | Oct 8, 2024 | |
| GMED Globus Medical | Maintains: Outperform | $78 → $80 | $74.27 | +7.72% | 4 | Oct 8, 2024 | |
| EW Edwards Lifesciences | Maintains: Outperform | $85 → $75 | $71.30 | +5.19% | 18 | Oct 8, 2024 | |
| DXCM DexCom | Maintains: Outperform | $130 → $120 | $74.23 | +61.65% | 3 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $85 → $95 | $85.98 | +10.49% | 12 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $125 → $130 | $116.51 | +11.58% | 10 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $65 | $31.89 | +103.83% | 1 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $6 → $3 | $0.54 | +460.75% | 8 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $16 → $7 | $4.99 | +40.28% | 8 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $260 | $195.61 | +32.92% | 2 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $386 | $363.34 | +6.24% | 15 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $71 | $70.26 | +1.06% | 5 | Feb 29, 2024 |
Intuitive Surgical
Oct 18, 2024
Maintains: Outperform
Price Target: $525 → $555
Current: $512.46
Upside: +8.30%
Johnson & Johnson
Oct 16, 2024
Maintains: Outperform
Price Target: $178 → $181
Current: $164.26
Upside: +10.19%
Medtronic
Oct 10, 2024
Upgrades: Outperform
Price Target: $98 → $105
Current: $91.83
Upside: +14.34%
Zynex
Oct 8, 2024
Maintains: Outperform
Price Target: $12 → $11
Current: $8.47
Upside: +29.95%
Zimmer Biomet Holdings
Oct 8, 2024
Maintains: Outperform
Price Target: $130 → $120
Current: $105.30
Upside: +13.96%
Teleflex
Oct 8, 2024
Maintains: Outperform
Price Target: $260 → $275
Current: $238.57
Upside: +15.27%
Penumbra
Oct 8, 2024
Maintains: Outperform
Price Target: $205 → $222
Current: $207.04
Upside: +7.23%
Globus Medical
Oct 8, 2024
Maintains: Outperform
Price Target: $78 → $80
Current: $74.27
Upside: +7.72%
Edwards Lifesciences
Oct 8, 2024
Maintains: Outperform
Price Target: $85 → $75
Current: $71.30
Upside: +5.19%
DexCom
Oct 8, 2024
Maintains: Outperform
Price Target: $130 → $120
Current: $74.23
Upside: +61.65%
Oct 8, 2024
Maintains: Outperform
Price Target: $85 → $95
Current: $85.98
Upside: +10.49%
Oct 8, 2024
Maintains: Outperform
Price Target: $125 → $130
Current: $116.51
Upside: +11.58%
Oct 2, 2024
Initiates: Outperform
Price Target: $65
Current: $31.89
Upside: +103.83%
Aug 8, 2024
Downgrades: Sector Perform
Price Target: $6 → $3
Current: $0.54
Upside: +460.75%
Aug 7, 2024
Maintains: Sector Perform
Price Target: $16 → $7
Current: $4.99
Upside: +40.28%
Aug 7, 2024
Reiterates: Outperform
Price Target: $260
Current: $195.61
Upside: +32.92%
Jul 31, 2024
Reiterates: Outperform
Price Target: $386
Current: $363.34
Upside: +6.24%
Feb 29, 2024
Reiterates: Sector Perform
Price Target: $71
Current: $70.26
Upside: +1.06%